comparemela.com

Latest Breaking News On - Medical trading down - Page 3 : comparemela.com

Avanos Medical (NYSE:AVNS) Updates FY24 Earnings Guidance

Avanos Medical (NYSE:AVNS) Updates FY24 Earnings Guidance
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Asia-pacific
Michael-greiner
Avanos-medical-company-profile
Avanos-medical-inc
Avanos-medical
Get-free-report
Medical-trading-down
North-america
Middle-east
Avanos-medical-daily

Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by AtonRa Partners

Inari Medical, Inc. (NASDAQ:NARI) Shares Sold by AtonRa Partners
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Mitchc-hill
Zurcher-kantonalbank-zurich-cantonalbank
Piper-sandler
William-hoffman
Mirae-asset-global-investments-co
Needham-company
Sg-americas-securities
Canaccord-genuity-group
Asset-management-one-co
Brown-advisory-inc
Nasdaq

Inari Medical (NASDAQ:NARI) Reaches New 52-Week Low at $36.73

Inari Medical (NASDAQ:NARI) Reaches New 52-Week Low at $36.73
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Piper-sandler
Mitchc-hill
William-hoffman
Canaccord-genuity-group
Allspring-global-investments-holdings
Needham-company
Inari-medical-inc
Vanguard-group-inc
Dimensional-fund-advisors
Principal-financial-group-inc
Inari-medical-company-profile

Microbot Medical (NASDAQ:MBOT) Price Target Lowered to $7.00 at HC Wainwright

Microbot Medical (NASDAQ:MBOT – Free Report) had its target price decreased by HC Wainwright from $8.00 to $7.00 in a report released on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for Microbot Medical’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 […]

United-kingdom
Microbot-medical-inc
Renaissance-technologies
Microbot-medical-company-profile
York-mellon-corp
Armistice-capital
Dimensional-fund-advisors
Vanguard-group-inc
Microbot-medical
Free-report
Medical-trading-down

Shockwave Medical (NASDAQ:SWAV) Downgraded by Leerink Partnrs

Leerink Partnrs lowered shares of Shockwave Medical (NASDAQ:SWAV – Free Report) from an outperform rating to a market perform rating in a report issued on Friday morning, Zacks.com reports. Other research analysts have also issued reports about the stock. CL King restated a neutral rating on shares of Shockwave Medical in a research note on […]

United-states
Douglas-evan-godshall
Trinh-phung
Leerink-partnrs
Deutsche-bank-aktiengesellschaft
Asset-management-one-co
Needham-company
Shockwave-medical-company-profile
Nasdaq
Quest-partners
Eversource-wealth-advisors
Lindbrook-capital

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.